It would be nice if you could add a dash of critical analysis to support your view and explain your rationale with facts.
Ann: FDA Advisory Committee Sets Review Date for Remestemcel-L, page-681
-
- There are more pages in this discussion • 174 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
92.0¢ |
Change
-0.005(0.54%) |
Mkt cap ! $1.056B | |||
| Open | High | Low | Value | Volume |
| 92.0¢ | 92.0¢ | 91.5¢ | $290.9K | 316.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 26 | 166361 | 91.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 92.5¢ | 53910 | 17 |
View Market Depth
| Last trade - 10.17am 18/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |